Skip to main content

. 1969 May;22(3):367–368. doi: 10.1136/jcp.22.3.367

Plasminogen activation and the coagulation process.

C R Prentice, G P McNicol, A S Douglas

PMCID: PMC474100 PMID: 5784986

367

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

IATRIDIS S. G., WILSON E. G., FERGUSON J. H., RIERSON H. A. Blood clotting activities of thrombolytic agents with special reference to a Hageman-like effect. Thromb Diath Haemorrh. 1960 Oct 1;5:50–60. [PubMed] [Google Scholar]
KWAAN H. C., MCFADZEAN A. J. Inhibition of fibrinolysis in vivo by feeding cholesterol. Nature. 1957 Feb 2;179(4553):260–260. doi: 10.1038/179260a0. [DOI] [PubMed] [Google Scholar]
NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
SHERRY S., FLETCHER A. P., ALKJAERSIG N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959 Apr;39(2):343–382. doi: 10.1152/physrev.1959.39.2.343. [DOI] [PubMed] [Google Scholar]
Turpie A. G., Forbes C. D., McNicol G. P. Idiopathic gangrene in African children. Br Med J. 1967 Sep 9;3(5566):646–648. doi: 10.1136/bmj.3.5566.646. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES